In the high-stakes world of oncology drug development, the line between a breakthrough and a setback is...
Nana Wu
In the rapidly evolving landscape of metabolic health, Eli Lilly has reached a new, albeit complex, milestone....
The scientific community, McMaster University, and the global landscape of cancer research are mourning the loss of...
In a significant boost for the European biotechnology landscape, Barcelona-based Ona Therapeutics has successfully closed an $86.6...
Published June 3, 2026 For practitioners of Vinyasa yoga, the sequence is iconic: a rhythmic, breath-linked dance...
By BioPharma Dive Staff Published June 3, 2026 The landscape of cellular immunotherapy is undergoing a tectonic...
In the world of animal advocacy, some stories transcend the typical narrative of pet adoption. They become...
NEW YORK — As the year 2025 draws to a close, the international Jewish community is marking...
In the high-stakes world of oncology, few diseases have remained as stubbornly lethal as pancreatic cancer. Often...
In the rapidly advancing era of precision medicine, the integration of genomics into routine clinical practice is...
